AU Stock MarketDetailed Quotes
ACW Actinogen Medical Ltd
- 0.026
- -0.001-3.70%
20min DelayMarket Closed May 17 16:00 AET
65.70MMarket Cap-4333P/E (Static)
0.027High0.025Low2.03MVolume0.026Open0.027Pre Close52.49KTurnover0.06052wk High0.12%Turnover Ratio2.53BShares0.01552wk Low-0.007EPS TTM44.78MFloat Cap1.777Historical HighLossP/E (Static)1.72BShs Float0.007Historical Low-0.006EPS LYR7.41%Amplitude--Dividend TTM5.20P/B1Lot Size--Div YieldTTM
About Actinogen Medical Ltd Company
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.
Company Profile
SymbolACW
Company NameActinogen Medical Ltd
Founded1999
MarketASX
Fiscal Year Ends06-30
Address109 Pitt Street Level 9, Suite 901
CitySydney
CountryAustralia
Zip Code2000
Phone+61 289647401
Websitehttps://www.actinogen.com.au
Company Executives
- Name
- Position
- Salary
- Steven Gourlay
- Executive Director, Chief Executive Officer and Managing Director
- --
- Dana Hilt
- Chief Medical Officer
- --
- Jeff Carter
- Chief Financial Officer
- --
- Tamara Miller
- Senior Vice President - Product Development
- --
- Geoffrey E.D Brooke
- Non-Executive Chairman of the Board
- --
- Malcolm John McComas
- Non-Executive Director
- --
- Nicki Vasquez
- Non-Executive Director
- --
- George Morstyn
- Non-Executive Director
- --
- Peter Webse
- Company Secretary
- --
- Fujun Li
- Head of Manufacturing
- --
- Michael Roberts
- Investor Relations
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg